Introduction
Transient nonlethal periods of ischemia and reperfusion confer profound cardioprotection in response to a prolonged lethal episode of ischemia-reperfusion, a phenomenon that has been termed ischemic preconditioning (IPC) (17) . Cardioprotection activates a signaling cascade involving PI3-kinase, AKT, ERK, PKCε, GSK-3, mitoK ATP , VDAC, cyclophilin D and mitochondrial permeability transition pore (10; 16) . Interestingly, the glycolytic enzyme hexokinase (HK) may be an important player in this scenario. We previously reported that in the isolated rat heart several cardioprotective interventions resulted in increased mitochondrial hexokinase activity, prior to the lethal episode of ischemiareperfusion (26) . In addition, the well-known cardioprotective volatile anesthetics isoflurane and sevoflurane have also been shown to increase mitochondrial hexokinase activity in the heart of the in vivo adult rat (28) . Finally, recent data demonstrate that hexokinase binding to mitochondria in cardiomyocytes confers profound protection against cell death by preventing permeability transition pore opening, indicating that mitochondrial HK binding may be a crucial component of the cardioprotective phenomenon (3; 15; 23) . This prompted us to further characterize HK during ischemiareperfusion in the intact heart and how IPC affected its localization and activity.
IPC is now known to affect signaling pathways, not only during the pre-ischemia episode, but also during ischemia and the reperfusion phase (6) . It has even been suggested that most of IPC's cardioprotective action is mediated by activating the so-called reperfusion injury salvage kinase (RISK) pathway during the early reperfusion phase (5) . A characteristic of this RISK pathway is its biphasic behavior (5) (6) (7) . It is unknown whether mitochondrial HK activity demonstrates a similar biphasic response upon IPC. In addition, part of the signal regulation of IPC is executed through subcellular translocations of the signaling molecules (2; 9). HK is reported to mainly localize in the cytosol or at the mitochondria (25) . However, Southworth et al. (22) showed recently that HK was also found in vesicles within the cardiomyocyte, supporting older data that HK may also be associated with membrane structures other than mitochondria (8) . Knowledge considering HK activity in this microsomal compartment and whether this HK compartment is also affected by IPC is currently missing. Finally, changes in HK activity can be the result of changes in the amount of HK protein present and/or posttranslational modification (15) of the protein. It is unknown whether IPC-induced changes in HK activity in the heart are due to protein translocation or merely modification. Of the known isoforms of HK, HKI and HKII are expressed in the heart. To examine whether altered mitochondrial hexokinase activity can be explained by changes in mitochondrial HK protein levels, we determined HKI and HKII protein contents in the mitochondrial fraction of the heart.
In the present study, we examined cardiac HK activity during pre-ischemia, ischemia and reperfusion in three different cellular compartments (cytosol, mitochondrial, microsomal) and how the spatial and temporal changes in HK activity were affected by IPC.
Additionally, we examined whether changes in mitochondrial HK activity were mimicked by changes in mitochondrial HK protein levels.
Material and Methods

Animals
Male Wistar rats (314 ± 2 g; Charles River, UK) were housed 2-4 per cage, subjected to a 12 h dark/12 h light cycle, with water and food given ad libitum. All procedures were approved by the animal Ethical Commission of the University of Amsterdam and conform to NIH guidelines on "Principle of laboratory animal care".
Heart perfusion.
Animals were anesthetized with pentobarbital (60 mg kg -1 ). Tracheotomy was performed and mechanical ventilation initiated. Following the opening of the thorax and administration of intravenous heparin (150 IU), the aorta was cannulated in situ, and perfusion was started before excision of the heart. The hearts were Langendorff-perfused at 37C with Krebs-Henseleit buffer containing (mM): 118 NaCl, 0.5 EDTA, 4.7 KCl , 2.25 
Heart homogenization and fractionation
At the designated time points, the heart was immediately minced in 8 ml ice-cold homogenization medium containing (mM): 250 sucrose, 20 Hepes (pH 7.4), 10 KCl, 1.5 MgCl 2 , EDTA, 1 dithiothreitol, 0.1 PMSF, 5 µg/ml leupeptin and aprotinin and 1 µg/ml pepstatin, and homogenized on ice. Part of the homogenate was not centrifuged and represented the whole-cell fraction. The remaining part of the homogenate was centrifuged at 800 g for 3 min to remove cellular debris, unbroken cells and nuclei. The supernatant was recovered and centrifuged at 10,000 g for 10 min. The pellet contained the crude mitochondrial fraction and the remaining supernatant was further centrifuged at 100,000 g for 30 min. The resultant pellet represented the microsomal fraction and the supernatant contained the cytosolic fraction. All centrifugation steps were performed at 4C. Fractions were quickly frozen at -80˚C until determination of enzyme activity or protein levels.
Determination of enzyme activities
The whole-cell homogenate, microsomal and mitochondrial fractions were treated with 0.5% Triton X-100 and 0.9 M KCl to maximally solubilize hexokinase (15), followed by centrifugation in an Eppendorff microcentrifuge (12.000 g; 10 s). Enzyme activities were determined in the supernatant of these fractions and in the cytosolic fractions. Hexokinase (HK) activity was measured spectrophotometrically at 25C with glucose-6-phosphate dehydrogenase (from Leuconostoc mesenteroides), glucose, ATP and NAD + , in the presence of rotenone (1 µM) to inhibit the mitochondrial respiration chain. Citrate synthase (CS), a mitochondrial marker, NADPH Cytochrome C reductase, a microsomal marker, and lactate dehydrogenase (LDH), a cytosolic marker and its venous release used as index of necrosis, were measured according to standard spectrophotometric procedures. Protein content of the different fractions was determined by the Bradford method. Percent HK activity was calculated from the formula ((fraction HK activity x fraction protein/total homogenate protein)/homogenate HK activity) x 100, according to Majewski et al. (14) . , time at which hearts were homogenized for both the control and ischemic preconditioning (IPC) groups. †, time at which venous effluent sample was taken for lactate dehydrogenase (LDH) determination. (B) Cardioprotective effects of IPC. IPC significantly increased the recovery of the rate-pressure-product (RPP) and decreased LDH enzyme efflux during the reperfusion period. *P<0.05 vs. CON.
Western blot analysis
Equal amounts of mitochondrial protein (10 µg/lane for HKI and 30µg/lane for HKII), microsomal protein (15 µg/lane for both HKI and HKII) and cytosolic protein (15 µg/lane for both HKI and HKII) were electrophorezed on a 10% SDS-polyacrylamide gel, transferred to a PVDF membrane, and probed with polyclonal antibodies for HKI (1:40,000; Santa Cruz), HKII (1:20,000; Chemicon) and the mitochondrial marker prohibitin I (PHBI;1:40,000; Cell Signaling) or the cytosolic marker alpha-tubulin (αTub; 1:40,000; Sigma). Unspecific binding of the antibody was blocked by incubation with 5% BSA solution. Proteins were detected using chemiluminescence, bands visualized by exposure to photographic film, and densitometry performed. Densities of HKI and HKII are expressed relative to the density of PHBI or αTub.
For determination of mitochondrial HK phosphorylation, phospho-Akt substrate antibody PAS (1:250; Cell Signaling) was used, as described by Miyamoto et al. (15) . Mitochondrial fractions were treated with 2 mM glucose-6-phosphate to specifically release HK from mitochondria (8; 24). After centrifugation, equal amounts of supernatant protein (30 µg/lane) were analyzed with PAS antibody, followed by reprobing with HKII to confirm PAS staining of HKII.
Statistics
Values are means ± SE. Testing for differences between control and IPC groups at the different time points was performed with the nonparametric Mann-Whitney U test (p<0.05).
Results
There were no differences in baseline characteristics between the different groups. The averaged values across groups amounted to an end-diastolic pressure of 4.4 ± 0.4 mmHg, a peak systolic pressure of 157 ± 4 mmHg, a heart rate of 300 ± 3 beats/min and a perfusion flow of 13.1 ± 0.5 ml/min/g. IPC was cardioprotective, as evidenced by an improved recovery of the rate-pressure-product from19 ± 5% in control to 43 ± 4% with IPC, and a reduction in LDH release during reperfusion from 1.85 ± 0.51 µmol/g/30 min reperfusion in control to 0.56 ± 0.04 µmol/g/30 min reperfusion with IPC ( Figure 1B) .
To examine the enrichment of the different subcellular fractions by our centrifugation procedure, we determined activities of subcellular-specific marker enzymes in each fraction ( Figure 2 ). The figure demonstrates that the mitochondrial marker CS is mostly present in the 10,000 g pellet fraction (Figure 2A ), although about 30% of CS was observed in the cytosolic fraction, presumably because of damage of mitochondria during homogenization of the tissue. The microsomal marker NADPH cytochrome C reductase is mostly enriched in the 100,000 g pellet fraction, although considerable activity remains in the two other fractions. The 100,000 g supernatant fraction is largely enriched with the cytosolic marker LDH, with almost no activity of LDH in the other two fractions ( Figure   2C ). From this analysis we designated the 10,000 g pellet as the mitochondrial-enriched fraction, the 100,000 g pellet as the microsomal-enriched fraction and the 100,000 g supernatant as the cytosolic-enriched fraction. The analysis of the marker enzymes at 35 min ischemia and 5 min reperfusion demonstrates that the degree of enrichment is not significantly affected throughout the ischemia-reperfusion protocol. Whole cell hexokinase activity, expressed per milligram of protein, amounted to 35.3 ± 7.1 nmol . min -1. mg protein, and was unaffected by IPC or ischemia-reperfusion. Figure 3 depicts HK activity determined in the microsomal-enriched fraction. Although a considerable amount of HK is found in this fraction (~30% of whole cell HK activity), IPC and ischemia-reperfusion was without any effect on the amount of HK activity in this fraction (Figure 3 ).
HK activity in the cytosolic-enriched fraction amounted to approximately 20% of whole cell HK activity before the period of lethal ischemia and was unaffected by IPC (Figure 4) . However, in the control group HK activity increased during the lethal ischemic period (at 35 min ischemia: 38.9 ± 3.1 % and 28.6 ± 3.2 % for control and IPC, respectively, P < 0.05; Figure 4 ), indicating solubilization of the enzyme during ischemia in the control group.
IPC prevented this solubilization to a large extent. HK activity in the cytosolic-enriched fraction of the control group declined during the reperfusion period to levels similar as the IPC group (Figure 4) . To further explore the increase in cytosolic HK activity at the end of ischemia, protein content of HKI and HKII was determined in the microsomal and cytosolic compartment ( Figure 5 ). It is shown that IPC specifically affects HKII during ischemia, without changes in HKI, and the data indicates that during ischemia a redistribution of HKII between the cytosolic and microsomal compartment occurs.
IPC resulted in an immediate increase of hexokinase activity in the mitochondrialenriched fraction (33.2 ± 1.1 % and 40.4 ± 2.1 % for control and IPC, respectively, P < 0.05; Figure 6 ), which declined during the period of lethal ischemia, followed by a second increase at 5 min of reperfusion (29.3 ± 2.7 % and 40.6 ± 3.7 % for control and IPC, respectively, P < 0.05; Figure 6 ). At 30 min of reperfusion significant differences between IPC and control were still present (31.5 ± 1.8 % and 37.3 ± 1.7 % for control and IPC, respectively, P < 0.05; Figure 6 ).
Results of the immunoblot analysis for HKI and HKII protein content in the mitochondrial fraction are given by figure 7. Both HKI and HKII were present in the mitochondrial fraction. IPC was without effect on HK I protein content ( Figure 7A ). However, IPC resulted in translocation of the HK II protein to the mitochondrial fraction, but only during reperfusion following the lethal ischemic event. HK II protein content remained unchanged immediately following the IPC event ( Figure 7B ). To explore whether the increased HK activity at baseline following IPC could be ascribed to increased HK phosphorylation, the phosphorylation status of HK was determined (Figure 8 ). Although
we were able to demonstrate PAS staining at the location of HKII in the mitochondrial fraction, indicating that HK is phosphorylated by Akt, IPC was without effect on HK phosphorylation.
Discussion
The new findings of this study may be summarized as follows: 1) IPC induces a biphasic response in HK activity within the mitochondrial fraction of the heart, with the first phase occurring immediately after the non-lethal ischemic IPC stimulus and the second phase The observation that a glycolytic enzyme (HK) is probably part of the IPC-induced protection of the mitochondria, supports the contention that alterations in glycolysis and mitochondria are both necessary to invoke the protective action of IPC (16; 17) . This is commensurate with work that demonstrated that mitochondrial activation after reversible ischemia is only delayed when glycolysis can take place (27; 29) . Recent data also showed that asides HK mitochondrial protection, non-mitochondrial HK may also contribute to protection due to its glucose phosphorylation capacity (23).
Interestingly, we were able to demonstrate that a considerable amount of hexokinase resides in a microsomal compartment. Southworth et al. (22) also reported the presence of HK in intracellular vesicles using electron microscopy techniques, which amount was not affected by ischemia. Other studies in heart and brain have shown HK binding to microsomes, possibly the endoplasmic reticulum (8; 13). Our study demonstrated that although no changes occurred in HK activity in this cellular compartment with ischemia or IPC, protein content of HKII in this compartment during ischemia is affected by IPC. It may therefore be suggested that the HKII compartmentalized in these microsomes is somehow involved in IPC during the index ischemia. Further research will be necessary to elucidate the precise origin of these microsomes and how they interact with HKII present in the cytosol and bound to mitochondria.
HK activity in the cytosol increased during the lethal period of ischemia, an effect that was largely mitigated by IPC. IPC was without effect on cytosolic HK activity before and after the lethal ischemic period. Thus, the temporal effect of IPC on HK activity in the cytosolic fraction is exactly opposite to its effect on HK activity in the mitochondrial fraction: IPC affects HK activity before and after the lethal ischemic period in the mitochondria, and during the lethal ischemic period in the cytosol. Part of the IPC-protection mediated by HK may therefore also rely on diminished cytosolic HK activity during prolonged ischemia.
It is possible that this reduction in cytosolic HK activity somehow contributes to the reported diminished lactate accumulation in IPC-hearts during prolonged ischemia (17) .
That cardioprotection differently affects location and activation of proteins involved in survival signaling has already been shown for PKC-isoforms and p38 MAPK (2; 18). It emphasizes the importance of timing and subcellular localization when describing these proteins and how they are affected by IPC. Not taking into account these factors may result in contradictory results between studies (2).
We observed that only HKII was significantly affected by IPC, and not HKI. It is known that insulin, and its downstream PI3K-Akt signaling pathway, regulates HKII and not HKI (19) . These data is therefore commensurate with the knowledge that IPC activates PI3K-Akt (5-7) that subsequently may have as one of its downstream targets translocation of HKII to the mitochondria (15) . The IPC-induced increased mitochondrial HK activity before the ischemic event could not be explained by translocation of HKII to the mitochondria, indicating that post-translational modification of HK may play a role.
Although HK phosphorylation was recently observed in isolated cardiomyocytes with pharmacological Akt activation (15), we were unable to show Akt-induced HK phosphorylation in the intact heart with IPC. Further studies are necessary to examine whether IPC in the intact heart results in post-translational modification of the HKII protein that affects the activity of the enzyme.
Methodological considerations
Hearts were perfused with 11 mM glucose, and physiological concentrations of glutamine, pyruvate and lactate, all of which are important substrates for the heart (11). However, fatty acids were not present in the perfusate, also because we are unable to obtain a stable preparation when albumin-bound fatty acids are added to the perfusate. Although it is known that, even under these conditions, the heart still derives >50% of its energy from the oxidation of endogenous stored fatty acids (21), our perfusion medium does not completely mimic the in vivo condition. We cannot exclude the possibility that perfusing the hearts without fatty acids may have affected our results concerning HK translocation (22) .
In the present study we employed 0.5% Triton and 0.9 M KCl to maximally solubilize HK from organelles and membrane HK-binding motifs (8) . Recently, Treberg et al. (24) demonstrated that this aggressive solubilization scheme also liberated permanently bound HK, which is not able to translocate between different subcellular fractions. In other words, the resolution to detect the amount of reversible bound enzyme is decreased when using this aggressive solubilization. Treberg et al. (24) demonstrated increased sensitivity for HK translocation with ischemia when using high ionic buffer instead only. When only a small amount of the total cellular HK is able to translocate, for example suggested by studies showing that only 1% of total HK is present in PKCε-VDAC-ANT complex (1), using a more sensitive technique to detect reversible bound HK only may result in larger HK changes with IPC as reported in the present study.
No interventions during IPC were performed to examine whether alterations in HK are causally linked to cardioprotection, e.g. using inhibitors of the PI3K-Akt-GSK-3β pathways to examine whether mitigation of IPC-induced cardioprotection is associated with abolishment of HK alterations. Such interventions will certainly need to be studied in the near future. However, this study was performed to first allow a full characterization of the spatial and temporal behavior of HK activity and protein isoform content during ischemia-reperfusion and how IPC affected these changes. The obtained data can now be used to more specifically examine whether the IPC-induced HK changes (e.g. mitochondrial HK activity and HK II protein content during the early phase of reperfusion) are correlated with the cardioprotective potential of IPC.
In this study we used 35 min ischemia, a period that results in a relatively large increase of dead cells during the reperfusion period. Analysis of IPC effects on subcellular protein function and translocation during this reperfusion period may therefore be influenced by the number of dead cells. We cannot exclude that at 30 min of reperfusion this was indeed partly the case, however, at that time no differences were observed whatsoever. It seems unlikely that at 5 min of reperfusion many cells were already dead, also knowing that postconditioning in this early period of reperfusion can still prevent cell dead. In addition, changes were only observed for HKII and not HKI, also supporting that the differences observed were due to specific IPC signaling on HKII, and not due to a general process of cell necrosis.
In conclusion, we have shown that IPC causes a biphasic response of HK activity in the mitochondrial compartment of the heart, with increased activity after the IPC stimulus and after the lethal ischemic period, but not during ischemia. During ischemia, IPC decreased HK activity in the cytosol. Protein content analysis showed that IPC specifically affected HKII and not HKI. Increased mitochondrial, and decreased cytosolic HK II protein content may explain the IPC-induced increased HK activity after the lethal ischemic period and decreased cytosolic activity during ischemia, respectively. The results demonstrate HKII to be regulated by IPC in an elaborate spatial and temporal fashion, suggesting a role for HKII as an integral part of IPC subcellular signaling.
